Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 0 | 0 | 0 | 0 | 183 |
| Gross Profit | N/A | N/A | N/A | N/A | 183 |
| Operating Expenses | 1,741 | 1,821 | 1,972 | 1,481 | 1,810 |
| Operating Income | -1,496 | -1,821 | -1,972 | -1,481 | -1,627 |
| Interest Expense | 1 | 0 | 1 | 1 | 451 |
| Other Income | 1,939 | -1,627 | 1,283 | 442 | 11,394 |
| Pre-tax Income | 443 | -3,449 | -690 | -1,040 | 9,316 |
| Net Income Continuous | 443 | -3,449 | -690 | -1,040 | 9,316 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 6,409 |
| Net Income | $443 | $-3,449 | $-690 | $-1,040 | $9,316 |
| EPS Basic Total Ops | 0.20 | -0.80 | -0.20 | -0.40 | 4.20 |
| EPS Basic Continuous Ops | 0.13 | -0.89 | -0.18 | -0.35 | 4.20 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 2.60 |
| EPS Diluted Total Ops | 0.20 | -0.80 | -0.20 | -0.40 | 4.20 |
| EPS Diluted Continuous Ops | 0.13 | -0.89 | -0.18 | -0.35 | 4.20 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 2.60 |
| EBITDA(a) | $-1,685 | $-1,779 | $-1,930 | $-1,440 | $-1,199 |